(Q34161049)

31 July 2017

1 reference

title

PPAR-gamma effects on the vasculature (English)

1 reference

31 July 2017

W A Hsueh

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Journal of Investigative Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

49

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

127-129

1 reference

Roles of PPARs in health and disease.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.34109

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.2310/6650.2001.34109

1 reference

31 July 2017

1 reference